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Parthenogenesis and somatic cell nuclear
transfer (SCNT) are two methods for deriving
embryonic stem (ES) cells that are genetically
matched to the oocyte donor or somatic cell
donor, respectively. Using genome-wide single
nucleotide polymorphism (SNP) analysis, we
demonstrate distinct signatures of genetic re-
combination that distinguish parthenogenetic
ES cells from those generated by SCNT. We
applied SNP analysis to the human ES cell line
SCNT-hES-1, previously claimed to have been
derived by SCNT, and present evidence that it
represents a human parthenogenetic ES cell
line. Genome-wide SNP analysis represents
a means to validate the genetic provenance of
an ES cell line.
INTRODUCTION
ES cells can be derived by several methods. Numerous
human ES cell lines have been derived from excess em-
bryos generated in the course of in vitro fertilization (IVF)
for the treatment of infertility. Parthenogenetic ES (pES)
cells have been derived from mouse and primate embryos
that result from artificial activation of oocytes without fer-
tilization (Cibelli et al., 2002; Robertson et al., 1983). ES
cells derived from embryos generated by somatic cell nu-
clear transfer (ntES) are of considerable interest as
a source of ES cells for research and tissue transplantation
(Rideout et al., 2002).
SCNT-hES-1 represents the first human ES cell line
purportedly generated by somatic cell nuclear transfer346 Cell Stem Cell 1, 346–352, September 2007 ª2007 Elsev(SCNT). In January of 2006, the editors of Science re-
tracted the paper by Hwang et al. (2004) (Kennedy,
2006) following findings by the Seoul National University
Investigation Committee (SNUIC) of research misconduct
(Investigation Committee Report, 2006). To investigate
whether the cell line was generated by SCNT or partheno-
genesis, the SNUIC commissioned genetic and epigenetic
analysis. DNA fingerprint analysis of nuclear donor cells
and SCNT-hES-1 indicated that all 40 of 40 informative
markers were shared with the oocyte donor, but 32 were
heterozygous while 8 were homozygous, leaving the ge-
netic provenance unexplained. Expression analysis of im-
printed genes and bisulphate sequencing of imprinted
gene loci suggested the line might represent the acciden-
tal isolation of a pES cell, but such studies alone are rarely
definitive. Because pES cells had been presumed to be
predominantly homozygous due to duplication of the
haploid genome (Kaufman et al., 1983; Liu et al., 2003),
the largely heterozygous pattern of polymorphic markers
seemed inexplicable, and thus the nature of the cell line
was left in doubt pending further definitive analysis by
the scientific community.
Recently, we have analyzed the patterns of genetic re-
combination in parthenogenetically derived murine ES
cell lines (Kim et al., 2007). The most efficient parthenoge-
netic protocols generate p(MII)ES cells, which show a pat-
tern of recombination that reflects the failure of indepen-
dent segregation of the sister chromatids during meiosis
II. Contrary to expectation, heterozygosity predominates
as a result of meiotic recombination, regardless of
whether parthenogenesis entails interruption of meiosis
II or I (Kim et al., 2007). When derived from hybrid F1
mice, p(MII)ES cells retain pericentromeric homozygosity
but show distal regions of heterozygosity. p(MI)ES cells
generated by disrupting karyokinesis of meiosis I (Kubiak
et al., 1991) show a pattern of recombination that reflectsier Inc.
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Recombination Signatures Distinguish NT-ES and pESFigure 1. Patterns of Genomic Homozygosity and Heterozygosity in ES Cells Derived by Nuclear Transfer and Parthenogenesis
from F1 Hybrid Mice
(A) Schematic of chromosomal genotypes predicted for ES cells of indicated types. Heterozygous region, HET; homozygous region, HOM.
(B) Depiction of SNP genotypes of a representative clone of male ntES cells and female p(MII)ES cells. Chromosome numbers are indicated along the
top, and markers are arrayed for the acrocentric murine chromosomes from centromeric (Cen; top) to telomeric (Tel; bottom) in blocks that span
a physical distance of 2 Mbp. Distance is marked in megabase pairs (Mbp). Orange blocks, homozygous (HOM) haplotypes; blue blocks, heterozy-
gous (HET) haplotypes.
(C) Graphs show the heterozygosity of SNP markers plotted against SNP marker distance from the centromere. n = 30 for ntES; n = 5 for p(MII). Slope
function describing the data is indicated (and rationale is provided in the Experimental Procedures). Error bars represent standard deviation.the failure of segregation of the parental chromosomes;
p(MI)ES cells retain peri-centromeric heterozygosity of ge-
netic markers and have characteristic distal regions of ho-
mozygosity. Because ES cells generated by SCNT should
be genetic clones of the donor, ntES cells generated from
a hybrid F1 mouse should show heterozygosity across all
loci, with only occasional deviations due to mitotic recom-
bination or somatic mutation.
Herein, we provide a thorough comparative analysis of
five novel pES cells and 30 nuclear transfer-derived mu-
rine ES cell lines, as well as SCNT-hES-1 by genome-
wide single nucleotide polymorphism (SNP) genotyping.
We analyze the murine samples in a manner that facilitates
comparison to a single cell line like SCNT-hES-1. Our
analysis shows that the recombination pattern of SCNT-
hES-1 is distinct from that of an ntES cell line and is con-
sistent with its derivation from a parthenogenetic embryo.
Thus, we conclude the derivation of SCNT-hES-1 repre-
sented the first reported successful isolation of human
pES cells.CellRESULTS
To determine the recombination patterns of ntES and pES
cells, we performed genome-wide SNP analysis (Moran
et al., 2006) in 30 euploid ntES cell lines generated from
hybrid strains of mice using a variety of donor cells and
compared the results with five newly derived p(MII)ES
cell lines (Figure 1). Cell lines derived from embryos pro-
duced by nuclear transfer from a hybrid F1 mouse show
complete heterozygosity at all informative SNP markers
(Figure 1B, left panels; and see Figure S1 in the Supple-
mental Data available with this article online), except for
rare occurrences of mitotic recombination or gene con-
version (e.g., Figure 1B, chromosome 14; Donahue et al.,
2006). There is no discernible relationship between rates
of marker recombination and marker distance from the
centromere (Figure 1C). Analysis of these five newly de-
rived murine p(MII)ES cell lines shows the characteristic
pericentromeric homozygosity (Figure 1B, right panel)
and increasing heterozygosity as marker distanceStem Cell 1, 346–352, September 2007 ª2007 Elsevier Inc. 347
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Recombination Signatures Distinguish NT-ES and pESFigure 2. SNP Genotype Data for SCNT-hES-1 and Three Representative Human ES Cell Lines
Genome-wide SNP mapping was performed using the GeneChip Human Mapping 500K SNP Array. (A) SCNT-hES-1. Genotyping data are depicted
as in Figure 1, except that short p arm of the human chromosomes project superiorly, while long q arm projects inferiorly. Note pericentromeric re-
gions of homozygosity for each chromosome. Conversion to homozygosity near telomeres is a reflection of the high frequency of double recombi-
nation in human chromosomes; (B) genotyping data are shown for three human ES cell lines (H9, BG01, and BG03) generated from fertilization em-
bryos. The patterns of panheterozygosity were identical for all three lines (excepting the X chromosome data, which show homozygosity in the male
line BG01); thus the data are presented as a composite. Orange blocks, homozygous (HOM) haplotypes; blue blocks, heterozygous (HET) haplotypes.
(C) Heterozygosity of SNP markers plotted against SNP marker distance from the centromere for the four cell lines. Slope function is indicated. Error
bars represent standard deviation.increases from the centromere (Figure 1C, right panels),
which show the existence of an identical pattern regard-
less of genetic background (B6D2F1) and ES cell isolation
method.
We used the GeneChip Human Mapping 500K SNP Ar-
ray set (Affymetrix) to investigate the patterns of marker
heterozygosity across all chromosomes of SCNT-hES-1,
based on the hypothesis that derivation by SCNT would
reveal genome-wide heterozygosity, whereas partheno-
genesis would be reflected by large blocks of homozygos-
ity, with the relationship of these blocks to the centromere
indicative of an interruption of either meiosis I or II. For
comparison, we determined the genome-wide patterns
of marker heterozygosity for the human ES cell lines H9,
BG01, and BG03, which were derived from embryos cre-
ated by IVF and confirmed to have normal karyotype. Gen-
otyping data for the hemizygous X chromosome from the
male human ES cell line, BG01, served as a control for
genotyping error rates. Across this single X chromosome,
2.3% of genotypes were reported as heterozygous (241
out of 10,536 calls). The error rates across this chromo-
some fit a normal distribution, with >99% of the blocks
of 1000 markers showing an error rate < 5%. Thus, we as-
signed homozygosity to any block of 1000 SNPs (with
a median distribution of one SNP per 2.5 kb) where the
heterozygous SNP frequency was at or below 5.0% (50
per 1000). (In such an analysis, the random variable is cal-
culated to be 49.429 in a normal distribution with an error
rate of 1%, meaning that as many as 49 individual hetero-348 Cell Stem Cell 1, 346–352, September 2007 ª2007 Elseviezygous SNPs per 1000 could occur by chance alone.) Us-
ing this parameter, all of the X chromosome regions from
BG01 fit the criteria of a homozygous chromosome, and
none of the other regions in chromosomes from H9,
BG01, and BG03 were called homozygous regions (Fig-
ure 2B). Differences between the heterozygous and
homozygous samples were evaluated by c2 analysis and
revealed a high degree of significance (p < 0.0001).
We analyzed the genotyping data for SCNT-hES-1 us-
ing the assumptions described above. Chromosome by
chromosome, homozygosity predominates at pericentro-
meric markers, and heterozygosity at more distal markers
(Figure 2A). When the SNP heterozygosity data for SCNT-
hES-1 are plotted with respect to the marker distance
from the centromere (Figure 2C), one observes the pattern
characteristic of mouse p(MII)ES cells (Figure 1C). This
analysis suggests that SCNT-hES-1 is indeed a human
p(MII)ES cell line.
Interestingly, chromosomes 7 and X show patterns of
complete homozygosity in SCNT-hES-1 (Figure 2A). The
hybridization signal for the human SNP genotyping array
showed monoallelic intensity for the X chromosome
markers and biallelic intensity for the markers on chromo-
some 7 (Komura et al., 2006). Cytogenetic analysis
showed a single copy of the X chromosome, and two cop-
ies of chromosome 7 (Figure S3). The original analysis
reported for SCNT-hES-1 revealed an XX karyotype,
suggesting that the subline of SCNT-hES-1 cells studied
here has undergone X chromosome loss. Prior DNAr Inc.
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Recombination Signatures Distinguish NT-ES and pESFigure 3. Bisulphite Sequencing of Three Differentially Methylated Regions in SCNT-hES-1 Cells
Circles represent the position and methylation status of individual CpG sites (filled, methylated; open, unmethylated), and each line represents
a unique clone of DNA. The numbering of the first and last CpG sites for H19 and SNRPN DMRs is relative to the transcriptional start sites shown,
and the numbering for KCNQ1OT1 DMR is according to the KCNQ1 sequence (AJ006345). A polymorphism in the KCNQ1OT1 DMR distinguished
the two alleles (blue and red lines). (A) H19. (B) KCNQ1OT1. (C) SNRPN.fingerprinting analysis of a highly polymorphic marker on
chromosome 7 showed heterozygosity (D75820; 08, 11;
SNUIC; Seoul National University Investigation Commit-
tee, 2006), whereas a repeat fingerprint analysis of the
subline studied here shows homozygosity (08-08), sug-
gesting that our line sustained loss of a single copy of
chromosome 7 and duplication of the remaining one,
a phenomenon that has been reported in cultured cell lines
(Donahue et al., 2006). Except for these differences, DNA
fingerprint analysis of the subline of SCNT-hES-1 studied
here using a set of 16 polymorphic markers distributed
across multiple chromosomes matched the fingerprinting
data reported for SCNT-hES-1 by the SNUIC (Table S1),
thereby confirming the identity of our line of SCNT-hES-
1 as the isolate reported by Hwang and colleagues.
Mammalian cells carry parent-of-origin patterns of DNA
methylation at imprinted gene loci due to differential
modification in male and female gametes, and parental-
specific DNA methylation is subsequently maintained
throughout development. To provide an additional assay
that can distinguish parthenogenetic from biparental cell
types, we analyzed the methylation status of three differ-
entially methylated regions (DMRs) in differentiated
SCNT-hES-1 cells by bisulphite treatment followed by se-
quencing. The normally paternally methylated H19 DMR
on chromosome 11 was predominantly unmethylated
(3/20 DNA strands methylated; significantly different
from the expected 10/20, p = 0.002, c2 test), whereas
the normally maternally methylated KCNQ1OT1 and
SNRPN DMRs on chromosomes 11 and 15, respectively,
were both fully methylated (22/22, p = 33 106 and 21/21,
p = 5 3 106, respectively; Figure 3). Importantly, a poly-
morphism was identified that distinguished the two
KCNQ1OT1 DMR alleles, thereby revealing that both al-
leles were fully methylated. This epigenotype contrasts
with normal differential methylation patterns observed at
the same DMRs in hES cells derived from fertilized em-
bryos (Rugg-Gunn et al., 2005a) and is characteristic of
parthenogenetic cells that contain two maternal genomesCelland no paternal genome. This epigenetic assessment
confirms our genome-wide SNP analysis, thereby provid-
ing more evidence that SCNT-hES-1 was derived from
a parthenogenetically activated embryo.
We have described a strategy for isolating murine pES
cells that are genetically matched to the oocyte donor at
major histocompatibility complex (MHC) loci (Kim et al.,
2007). The mouse MHC cluster is located 32 Mbp from
the centromere on chromosome 17. This region is pre-
dicted to be 37.6% heterozygous in p(MII)ES cells (Fig-
ure 1C) and 87.2% heterozygous in p(MI)ES cells (Kim
et al., 2007). We observed MHC heterozygosity in 33%
of p(MII)ES cells (24/72) and 87% of p(MI)ES cells
(13/15) (Kim et al., 2007), in close agreement with our
prediction.
By applying a similar analysis in human samples, we can
determine the probability that any given human pES cell
line will be genetically identical at the maternal histocom-
patibility loci to the oocyte donor. The recombination fre-
quency of the human genome is higher than the mouse
genome (Kong et al., 2002), and the human female genetic
map is 72% larger than the male due to a higher frequency
of recombination in female meiosis (Kong et al., 2002). The
female human chromosome 6, which contains the human
MHC cluster, has 241.55 cM of genetic distance over
190.87 Mb of physical distance (an average of 1.26 cM/
Mb) (Kong et al., 2002). Thus, human chromosome 6 will
reach peak heterozygosity, and thus sustain at least one
crossover, within 39.7 Mb from the centromere. The gen-
otyping data available for SCNT-hES-1 demonstrate that
peak heterozygosity is indeed reached at the predicted
physical distance around 38.9 Mb from the centromere
(Figure 2C). The human MHC cluster is located 28.3–
31.5 Mb from the centromere on chromosome 6. Thus,
we predict that 70.9% of human p(MII)ES cells will show
heterozygosity at the MHC loci and thereby match the
oocyte donor in an autologous manner (Figure 2C).
We determined the HLA type for SCNT-hES-1 and
found it to be homozygous: HLA-A (31, 31), HLA-B (35,Stem Cell 1, 346–352, September 2007 ª2007 Elsevier Inc. 349
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(0302, 0302). Genetic analysis of the MHC region of
SCNT-hES-1 indicates that a crossover event occurred
telomeric to the MHC-gene cluster (Figure S2C). Thus,
SCNT-HES-1 represents a hemizygous HLA match to
the oocyte donor.
DISCUSSION
Both parthenogenesis and nuclear transfer represent
strategies for generating histocompatible ES cells for po-
tential therapeutic use. Whereas nuclear transfer could
potentially provide a nearly exact match to the nuclear
donor’s immune identity (matching nuclear, but not mito-
chondrial, genes), parthenogenesis could provide an ex-
act match to the oocyte donor’s genome (both nuclear
and mitochondrial). Moreover, parthenogenesis could
provide a source of cells that are either heterozygous or
homozygous for major histocompatibility alleles, thereby
allowing either complete MHC matching to the oocyte do-
nor, or in the case of MHC homozygosity, partial MHC
matching to a substantial population of unrelated trans-
plant recipients (Taylor et al., 2005). Parthenogenesis is
a more efficient means of generating embryos and ES
cell lines than nuclear transfer, and to date human nuclear
transfer has not been successfully used to generate an
ES cell.
During experimental parthenogenesis in the mouse, cy-
tochalasin is added to prevent the extrusion of the second
polar body and to preserve the diploid state. In contrast, in
human oocytes cytochalasin is not necessary to retain
diploidy (De Sutter et al., 1992; Santos et al., 2003; Taylor
and Braude, 1994), and a kinase inhibitor such as 6-di-
methylaminopurine (DMAP) suffices to initiate diploid
parthenogenetic development (Szollosi et al., 1993). The
derivation protocol of SCNT-hES-1 employed DMAP after
oocyte activation with a calcium ionophore. Thus, the pro-
tocols for generating ntES cell lines typically involve the
same steps of artificial oocyte activation as parthenogen-
esis, and in the case of SCNT-hES-1, there was apparently
no enucleation. Alternatively, there was refusion of the first
polar body after enucleation (Wakayama et al., 2007). Re-
gardless of the mechanism, the result was development of
a diploid parthenogenetic embryo. To rule out a partheno-
genetic origin of SCNT-hES-1, Hwang and colleagues of-
fered evidence for expression of two imprinted genes that
are normally only expressed from the paternally inherited
allele. However, such aberrant expression can result
from epigenetic instability, which is frequently observed
in mouse pES cells (Dean et al., 1998; Feil et al., 1997).
We have shown that methylation analysis of germline-
acquired DMRs is a more robust indicator of epigenotype,
although this too can alter following extensive in vitro cul-
ture (Humpherys et al., 2001; Mitalipov et al., 2007; Rugg-
Gunn et al., 2005b).
For trials of nuclear transfer, if the somatic cell nucleus
and the recipient oocytes come from different donors,
the genomic DNA of any resulting ntES cells can be readily350 Cell Stem Cell 1, 346–352, September 2007 ª2007 Elsevdistinguished from parthenogenetic derivatives that might
mistakenly arise. However, if nuclear transfer is performed
using autologous oocytes from the somatic-cell donor, as
in the case of SCNT-hES-1, all genetic markers will be
shared, and selection of a small number of markers could
mistakenly lead to the conclusion of genetic identity.
Importantly, pES cells differ from ntES cells and ES cells
generated from fertilized embryos in that certain regions
of the genome show homozygosity and are thus only hap-
loidentical to the oocyte donor. Genome-wide SNP geno-
typing is a reliable means of distinguishing parthenoge-
netic derivatives from those derived by nuclear transfer,
because parthenogenetic embryo development incurs
a diagnostic recombination signature that reflects the
unique chromosomal dynamics of meiosis. Distinguishing
ntES cells from those derived from fertilization embryos
requires unequivocal demonstration of genetic identity
to the somatic cell donor, or in cases where the somatic
cell donor and oocyte donor differ, demonstration that
the mitochondrial DNA is distinct from the somatic cell
and instead derives from the oocyte.
The evidence indicates that SCNT-hES-1 represented
the first reported isolation of a human pES cell. Despite
the feasibility of generating patient-specific ES cells from
females by parthenogenesis for use in research and po-
tential therapy, concerns about their safety and differenti-
ation efficiency remain. Mouse parthenogenetic embryos
are unable to complete full development due to the
absence of paternally expressed imprinted genes, and
tissues derived from pES cells appear to have growth de-
fects (Hernandez et al., 2003). However, recent reports
show that genetic manipulation of a small number of im-
printed genes (H19/Igf2; Dlk1-Gtl2) can enhance the qual-
ity of the parthenogenetic embryo and sustain full organis-
mal development (Kono et al., 2004; Wu et al., 2006). Also,
stable and functional hematopoietic engraftment has
been reported from parthenogenetic cells in mice (Eckardt
et al., 2007) and in a rare human parthenogenetic chimera
(Strain et al., 1995). If careful genetic and functional anal-
yses of tissues derived from human pES cells show them
to be safe and effective, then pES cells might represent
a favorable source for tissue replacement therapies.
EXPERIMENTAL PROCEDURES
Cytogenetic and Molecular Analysis
Cytogenetic analysis was performed by the Molecular Cytogenetics
Core Facility of Memorial Sloan-Kettering Cancer Center, USA. DNA
fingerprinting was performed by Cell Line Genetics, USA with the
Powerplex 16 kit (Promega) (Goncalves et al., 2002). HLA typing was
performed by the Blood Center of Wisconsin, USA with LABtype
SSO kit (One Lambda) (Colinas et al., 2000). Human SNP analysis
was performed by Affymetrix USA and the Molecular Genetics Core
Facility of Children’s Hospital Boston and Harvard Medical School
with GeneChip Human Mapping Nsp Sty Array kit (Affymetrix) (Komura
et al., 2006); mouse SNP analysis was performed at the Broad Institute
NCRR Center for Genotyping and Analysis using the Illumina multi-
plexed allele extension and ligation method (Golden Gate) with detec-
tion using oligonucleotide probes covalently attached to beads that
are assembled into fiber-optic bundles (Bead Array) (Moran et al.,
2006).ier Inc.
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In a prior analysis of SNP data from pES cells, we pooled data for each
chromosome among multiple pES cells to calculate the relationship
between marker heterozygosity and distance of the marker from the
centromere (Kim et al., 2007). In order to generate a meaningful com-
parison of the pattern of genetic recombination in a single cell line
(SCNT-hES-1) with murine ntES and pES cell lines, we analyzed the
SNP data for five newly derived euploid p(MII)ES cell lines by pooling
data for all markers at a given distance from the centromere across
all chromosomes in individual cell lines (as illustrated in Figure 1C),
thereby reducing the clonal variation we observed in the prior SNP
analysis (Kim et al., 2007).
Procurement of SCNT-hES-1 and Handling of Research
Materials and Data
DNA and mRNA extracts of SCNT-hES-1 and SCNT-hES-1 cell line
were obtained from the Department of Theriogenology and Biotech-
nology, College of Veterinary Medicine, Seoul National University by
Drs. Moore and Pederson under a material transfer agreement be-
tween their respective institutions and the Seoul National University.
Research data, but not materials, were exchanged among the authors
in the preparation of this manuscript.
Supplemental Data
Supplemental Data include three figures, one table, and Supplemental
References and can be found with this article online at http://www.
cellstemcell.com/cgi/content/full/1/3/346/DC1/.
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